Updated pharmacokinetic considerations for the use of antimalarial drugs in pregnant women.
Brioni R MooreTimothy M E DavisPublished in: Expert opinion on drug metabolism & toxicology (2020)
Changes in antimalarial drug disposition in pregnancy are well described, yet pregnant women continue to receive treatment regimens optimized for non-pregnant adults. Contemporary in silico modeling has recently identified a series of alternative dosing regimens that are predicted to provide optimal therapeutic efficacy for pregnant women.